Biomanufacturing Featured Articles

31. Distributed Cell Therapy Manufacturing Trade-Offs You Should Know About 3/5/2025

    For all its patient-centered benefits, producing personalized medicine at the point of care has pitfalls that are worth careful consideration.

32. The Rise Of AI-Powered Drones In Clinical Logistics And Supply Chains 3/5/2025

    Drone technology has significantly advanced, benefiting from improved connectivity, GPS accuracy, and AI/ML.

33. Supply Chain Corrective Action Report Checklist 2/7/2025

    Discover how to shape a corrective action plan that provides a structured method for resolving supply chain issues, emphasizing root cause analysis, accountability, and continuous improvement.

34. Cell Culture Media Quality Control Strategies 2/5/2025

    Cell culture media quality is key for lab success. Learn essential sourcing, storage, and handling strategies to prevent contamination and costly setbacks.

35. Outsourcing To ISO 17025 Accredited Suppliers 1/28/2025

    Discover the advantages of outsourcing equipment calibration to ISO 17025 accredited suppliers, including cost efficiency and regulatory assurance, in our detailed analysis. Read more to transform your calibration processes.

36. Digital Certificates Of Analysis: A Vision For The Transfer Of Quality Data 1/23/2025

    The pharma/biotech industry must ramp up adoption of digital certificates of analysis, which are transforming the way quality data is transferred between organizations in the supply chain.

37. Tune Therapeutics' 2025 Epigenome Editing Outlook 1/10/2025

    Chief Scientific Officer Derek Jantz talks about recent key innovations in gene therapy and RNA technology while considering what milestones we might see in 2025.

38. Will FDA Finally Enforce DSCSA Interoperability In 2025? 12/26/2024

    Two experts weigh in on the persistent problems surrounding the Drug Supply Chain Security Act and its upcoming enforcement deadlines.

39. 7 Trends In Global Vaccine Development 2025 12/19/2024

    Five years post-COVID, global vaccine development is experiencing a surge of innovation. Let's examine seven key trends shaping the future of vaccine manufacturing and accessibility in 2025.

40. Inside Interius' Global Regulatory Strategy 12/13/2024

    Interius BioTherapeutics' lentiviral gene therapy INT2104, which creates CAR T and CAR NK cells in vivo, headed to clinical trials in Australia where the company dosed a first patient with a B-cell malignancy. CEO Phil Johnson, M.D. gave us a look inside the company's global regulatory strategy.